Valeant Picks New CFO From Zoetis in Ongoing Company ShakeupBy
Paul Herendeen replaces Rob Rosiello as Valeant seeks comeback
Drugmaker’s shares rise 9.2 percent on news of new CFO
Valeant Pharmaceuticals International Inc. chose Paul Herendeen, a former executive at Warner Chilcott Plc and veterinary drugmaker Zoetis Inc., as its new chief financial officer in an ongoing leadership shakeup sparked by an accounting scandal.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.